ATC
MGNX icon

Adirondack Trust Company’s MacroGenics MGNX Stock Holding History

Adirondack Trust Company’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-294
Closed -$4.33K – 500
2024
Q1 		$4.33K Hold
294
– – ﹤0.01% 418
2023
Q4 		$5.27K Buy
+294
New +$2.03K ﹤0.01% 404

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adirondack Trust Company's MGNX Position: Q2 2024 in Review

Adirondack Trust Company sold out of MacroGenics (MGNX) in Q2 2024, closing a stake of 294 shares — an estimated $4.33K sold.

Adirondack Trust Company first reported a position in MGNX in Q4 2023 and held it in 2 quarters. The position peaked at $5.27K in Q4 2023. 146 funds tracked by Wall St. Rank hold MGNX as of Q2 2024.

  • Adirondack Trust Company reported no remaining MacroGenics position as of Q2 2024 after selling out during the quarter.
  • Adirondack Trust Company sold 294 MacroGenics shares in Q2 2024, an estimated $4.33K.
  • Adirondack Trust Company first reported a position in MacroGenics in Q4 2023 and held it in 2 quarters.
  • Adirondack Trust Company's MacroGenics position peaked at $5.27K in Q4 2023.
  • 146 funds tracked by Wall St. Rank held MacroGenics as of Q2 2024.

Based on Adirondack Trust Company's 13F filing for Q2 2024, filed 9 Jul 2024.